Endocrine regulation of testicular function in men: Implications for contraceptive development

Molecular and Cellular Endocrinology

Volumn 186, Issue 2, 2002, Pages 205-209

  Amory, John K ^a   Bremner, William ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Contraception; FSH; LH; Male; Spermatogenesis; Testosterone

Indexed keywords

CYPROTERONE ACETATE; DESOGESTREL; FOLLITROPIN; GESTAGEN; GONADORELIN; GONADOTROPIN; INHIBIN; LEVONORGESTREL; LUTEINIZING HORMONE; TESTIS PEPTIDE HORMONE; TESTOSTERONE; TESTOSTERONE ENANTATE; TESTOSTERONE UNDECANOATE;

CENTRAL NERVOUS SYSTEM; CLINICAL TRIAL; CONFERENCE PAPER; CONTRACEPTION; FEEDBACK SYSTEM; GENE MUTATION; GONADORELIN RELEASE; GONADOTROPIN RELEASE; HORMONAL REGULATION; HORMONE ACTION; HORMONE STRUCTURE; HUMAN; HYPOPHYSIS; HYPOTHALAMUS; MALE GENITAL SYSTEM; METABOLITE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SPERMATOGENESIS; TESTIS; TESTIS FUNCTION; TESTOSTERONE SYNTHESIS;

EID: 0037168913     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0303-7207(02)00030-8     Document Type: Conference Paper

References (39)

1. Serum inhibin B levels reflect Sertoli cell function in normal men with testicular dysfunction
2. A lower dosage levonorgestrel and testosterone combination effectively suppresses spermatogenesis and circulating gonadotropin levels with fewer metabolic effects than higher dosage combinations
3. Desogestrel plus testosterone effectively suppresses spermatogenesis but also causes modest weight gain and HDL suppression
4. Comparison of a gonadotropin releasing-hormone antagonist plus testosterone (T) versus T alone as potential male contraceptive regimens
5. The direct pituitary effect of testosterone to inhibit gonadotropin secretion in men is partially mediated by aromatization to estrogen
6. Combined administration of levonorgestrel and testosterone induces more rapid and effective suppression of spermatogenesis than testosterone alone: A promising male contraceptive approach
7. Intramuscular injection of testosterone undecanoate for the treatment of male hypogonadism: Phase I studies
8. The temporal relationship between gonadotropin releasing hormone (GnRH) and luteinizing hormone (LH) secretion in ovariectomized ewes
9. Prospects for new hormonal male contraceptives
10. Impairing follicle-stimulating hormone (FSH) signaling in vivo: Targeted disruption of the FSH receptor leads to aberrant gametogenesis and hormonal imbalance
11. Would women trust their partners to use a male pill?
12. An activating mutation of the follicle stimulating hormone receptor autonomously sustains spermatogenesis in a hypophysectomized man
13. Inhibin-B: A likely candidate for the physiologically important form of inhibin in men
14. Male pseudohermaphroditism due to a homozygous missense mutation of the luteinizing hormone receptor gene
15. Follicle-stimulating hormone is required for ovarian follicle maturation but not male fertility
16. Testicular and ovarian resistance to luteinizing hormone caused by inactivating mutations of the luteinizing hormone-receptor gene
17. Potential impact of hormonal male contraception: Cross-cultural implications for development of novel preparations
18. Modulation of pulsatile gonadotropin secretion by testosterone in men
19. Stimulation of sperm production in gonadotropin-suppressed normal men by physiological dosages of human luteinizing hormone
20. Chronic human chorionic gonadotropin administration in normal men: Evidence that follicle stimulating hormone is necessary for the maintenance of quantitatively normal spermatogenesis in man
21. The relative roles of follicle-stimulating hormone and luteinizing hormone in the control of inhibin secretion in normal men
22. A combined regimen of cyproterone acetate and testosterone enanthate as a potentially highly effective male contraceptive
23. An oral regimen of cyproterone acetate and testosterone for spermatogenic suppression in men
24. Repeated intramuscular injections of testosterone undecanoate for substitution therapy in hypogonadal men
25. Combined administration of a gonadotropin-releasing hormone antagonist and testosterone in men induces reversible azoospermia without loss of libido
26. Male hypogonadism due to a mutation in the gene for the β-subunit of follicle-stimulating hormone
27. Testosterone administration inhibits gonadotropin secretion by an effect on the human pituitary
28. A constitutively activating mutation of the luteinizing hormone receptor in familial male precocious puberty
29. The follicle-stimulating hormone receptor: Biochemistry, molecular biology, physiology and pathophysiology
30. Men homozygous for an inactivating mutation of the follicle-stimulating hormone (FSH) receptor gene present variable suppression of spermatogenesis and fertility
31. Induction of azoospermia in normal men with combined Nal-Glu gonadotropin-releasing hormone and testosterone enanthate
32. Specific regulatory actions of dihydrotestosterone and estradiol: The dynamics of FSH secretion and clearance in humans
33. Differential sex steroid negative feedback regulation of pulsatile follicle-stimuating hormone secretion in healthy older men: Deconvolution analysis and steady-state sex-steroid hormone infusions in frequently sampled healthy older individuals
34. Hypogonadism cause by a single amino acid substitution in the β subunit of luteinizing hormone
35. Contraceptive efficacy of testosterone-induced azoospermia in normal men
36. Contraceptive efficacy of testosterone-induced azoospermia and oligozoospermia in normal men
37. Oral progestogen combined with testosterone as a potential male contraceptive: Additive effects between desogestrel and testosterone enanthate in suppression of spermatogenesis, pituitary-testicular axis, and lipid metabolism
38. A pharmacokinetic study of injectable testosterone undecanoate in hypogonadal men
39. A clinical trial of injectable testosterone undecanoate as a potential male contraceptive in normal Chinese men